Funding Opportunities

• Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R21 Clinical Trial Optional)
  (PA-18-354)
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Healthy Habits: Timing for Developing Sustainable Healthy Behaviors in Children and Adolescents (R01 Clinical Trial Optional)
  (PA-18-355)
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Population Health Interventions: Integrating Individual and Group Level Evidence (R01) Clinical Trials Not Allowed
  (PA-18-356)
  Office of Behavioral and Social Sciences Research
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Research Scientist Development Award (Parent K01 - Clinical Trial Required)
  (PA-18-363)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not Allowed)
  (PA-18-369)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
  (PA-18-370)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Independent Scientist Award (Parent K02 - Independent Clinical Trials Not Allowed)
  (PA-18-371)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018.
• Mentored Clinical Scientist Research Career Development Award (Parent K08 - Independent Clinical Trial Required)
  (PA-18-372)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials)
  (PA-18-373)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mentored Patient-Oriented Research Career Development Award (Parent K23 - Clinical Trial Required)
  (PA-18-374)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018.
• Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trials Not Allowed)
  (PA-18-375)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.The first standard due date for this FOA is February 12, 2018.
• Family-Centered Self-Management of Chronic Conditions (R21 Clinical Trial Optional)
  (PA-18-380)
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• A Family-Centered Self-Management of Chronic Conditions (R01 Clinical Trial Optional)
  (PA-18-383)
  National Institute of Nursing Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Population Health Interventions: Integrating Individual and Group Level Evidence (R01) - Clinical Trial Optional
  (PA-18-385)
  Office of Behavioral and Social Sciences Research
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01 Clinical Trial Optional)
  (PA-18-386)
  National Institute of Nursing Research
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• mHealth Tools for Individuals with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R21 Clinical Trial Optional)
  (PA-18-389)
  National Institute of Nursing Research
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Clinical Trial Required)
  (PA-18-393)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018.
• Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - No Independent Clinical Trials)
  (PA-18-394)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Mentored Quantitative Research Development Award (Parent K25 - Clinical Trial Required)
  (PA-18-395)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018.
• Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)
  (PA-18-396)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Heart, Lung, and Blood Institute
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard due date for this FOA is February 12, 2018.
• Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
  (PA-18-403)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of General Medical Sciences
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. However, please note that not all participating Institutes and Centers accept applications at every standard date. Applicants should consult the Table of IC-Specific Information, Requirements and Staff Contacts for specific due dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)
  (PA-18-404)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Allergy and Infectious Diseases
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. However, please note that not all participating Institutes and Centers accept applications at every standard date. Applicants should consult the Table of IC-Specific Information, Requirements and Staff Contacts for specific due dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Pilot and Feasibility Therapeutic Clinical Trials in Diabetes, and Endocrine and Metabolic Diseases (R21- Clinical Trial Required)
  (PA-18-405)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed
  (PA-18-406)
  Office of Behavioral and Social Sciences Research
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Population Health Interventions: Integrating Individual and Group Level Evidence (R21) - Clinical Trials Optional
  (PA-18-407)
  Office of Behavioral and Social Sciences Research
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional)
  (PAR-18-021)
  National Cancer Institute
  Application Receipt Date(s): February 27, 2018; June 29, 2018; October 26, 2018; February 26, 2019; June 28, 2019; October 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on dates.
• Ancillary Studies to Identify Behavioral and/or Psychological Phenotypes Contributing to Obesity (R01 Clinical Trial Optional)
  (PAR-18-105)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): February 28, 2018; June 28, 2018; February 28, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R18 Clinical Trial Required)
  (PAR-18-106)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care (R34 Clinical Trial Required)
  (PAR-18-107)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 1, 2018; November 1, 2018; March 1, 2019; and November 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NCMRR Early Career Research Award (R03 Clinical Trial Optional)
  (PAR-18-211)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional)
  (PAR-18-212)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Nursing Research
  Application Receipt Date(s): March 30, 2018, March 29, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
  (PAR-18-213)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional)
  (PAR-18-218)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
  (PAR-18-219)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 27, 2018; July 25, 2018; March 27, 2019; July 25, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional)
  (PAR-18-230)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): February 23, 2018; June 22, 2018; October 23, 2018; February 22, 2019; June 24, 2019; October 23, 2019; February 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Addiction (U19 Clinical Trial Optional)
  (PAR-18-231)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): February 23, 2018; June 22, 2018; October 23, 2018; February 22, 2019; June 24, 2019; October 23, 2019; February 24, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required)
  (PAR-18-232)
  National Institute of Mental Health
  Application Receipt Date(s): March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required)
  (PAR-18-233)
  National Institute of Mental Health
  Application Receipt Date(s): March 19, 2018; July 18, 2018; November 19, 2018; March 19, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program (U01 Clinical Trial Optional)
  (PAR-18-244)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): March 8, 2018; July 11, 2018; November 9, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Exploratory CTSA Collaborative Innovation Awards (R21 Clinical Trial Optional)
  (PAR-18-245)
  National Center for Advancing Translational Sciences
  National Center for Advancing Translational Sciences
  Application Receipt Date(s): March 29, 2018, July 30, 2018, November 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional)
  (PAR-18-262)
  National Institute of General Medical Sciences
  Application Receipt Date(s): March 27, 2018; March 27, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
  (PAR-18-268)
  National Institute of Mental Health
  Application Receipt Date(s): February 23, 2018, June 26, 2018, October 24, 2018, by 5:00 PM local time of applicant organization.
• Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional
  (PAR-18-352)
  Office of Behavioral and Social Sciences Research
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Disease Prevention
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Education and Health: New Frontiers (R21)- Clinical Trial Optional
  (PAR-18-362)
  Office of Behavioral and Social Sciences Research
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)
  (PAR-18-366)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)
  (PAR-18-367)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional
  (PAR-18-378)
  Office of Behavioral and Social Sciences Research
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  National Center for Complementary and Integrative Health
  Office of Research on Women's Health
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Education and Health: New Frontiers (R01)- Clinical Trial Optional
  (PAR-18-387)
  Office of Behavioral and Social Sciences Research
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Education and Health: New Frontiers (R03) - Clinical Trial Optional
  (PAR-18-388)
  Office of Behavioral and Social Sciences Research
  National Institute on Aging
  National Cancer Institute
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
  (RFA-CA-18-002)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2018; May 29, 2018; September 28, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
  (RFA-CA-18-003)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2018; May 29, 2018; September 28, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed)
  (RFA-CA-18-004)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2018; May 29, 2018; September 28, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed)
  (RFA-CA-18-005)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2018; May 29, 2018; September 28, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Elucidating HIV and HIV-treatment Associated Metabolic/Endocrine Dysfunction (R01 Clinical Trial Optional)
  (RFA-DK-17-036)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): March 13, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
• The Role of the Microbiome in the Developmental Origins of Health and Disease (DOHaD) (R01 Clinical Trial Not Allowed)
  (RFA-ES-18-005)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): March 14, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R41/R42)
  (RFA-HD-18-101)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): January 22, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Advancing the Science of Multipurpose Technology for the Prevention of HIV and Unintended Pregnancy (R43/R44)
  (RFA-HD-18-102)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): January 22, 2018, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial Optional)
  (RFA-OD-18-001)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Food and Drug Administration
  Office of Disease Prevention
  U.S. Food and Drug Administration, Center for Tobacco Products
  Application Receipt Date(s): February 13, 2018, July 17, 2018, February 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Regulatory Science (R01 Clinical Trial Optional)
  (RFA-OD-18-002)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Food and Drug Administration
  Office of Disease Prevention
  U.S. Food and Drug Administration, Center for Tobacco Products
  Application Receipt Date(s): February 13, 2018, July 17, 2018, February 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Tobacco Regulatory Science (R21 Clinical Trial Optional)
  (RFA-OD-18-003)
  National Institutes of Health
  National Institute on Alcohol Abuse and Alcoholism
  National Cancer Institute
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
  National Heart, Lung, and Blood Institute
  Food and Drug Administration
  Office of Disease Prevention
  U.S. Food and Drug Administration, Center for Tobacco Products
  Application Receipt Date(s): February 13, 2018, July 17, 2018, February 13, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for the Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.